US health department hands over Medicaid personal data to ICE
Giving ICE access to the personal data of Medicaid enrollees marks an escalation in President Donald Trump's hardline immigration policies. It may also raise privacy concerns under the Health Insurance Portability and Accountability Act, known as HIPAA.
A Department of Health and Human Services spokesperson said sharing data between the Centers for Medicare and Medicaid Services and the Department of Homeland Security, which oversees ICE, fell within the department's legal authority.
"With respect to the recent data sharing between CMS and DHS, HHS acted entirely within its legal authority – and in full compliance with all applicable laws – to ensure that Medicaid benefits are reserved for individuals who are lawfully entitled to receive them," the spokesperson said.
The agreement was first reported earlier on Thursday by the Associated Press, which said it was signed on Monday.
The Medicaid health program for low income people is jointly funded by the federal government and states.
Immigrants who are in the U.S. illegally are not eligible for Medicaid under federal law, but 14 states and the District of Columbia provide coverage for eligible children regardless of immigration status, and seven states and DC do so for adults.
"CMS is aggressively cracking down on states that may be misusing federal Medicaid funds to subsidize care for illegal immigrants. This oversight effort – supported by lawful interagency data sharing with DHS – is focused on identifying waste, fraud, and systemic abuse," the HHS spokesperson said.
The spokesperson did not address questions from Reuters on the type of data being shared or on how HHS would ensure HIPAA protections are upheld. The AP, citing a copy of the data sharing agreement, said the data included home addresses and ethnicities.
The agreement is the latest in a series of moves by the health department in support of the Trump administration's immigration crackdown and comes a week after it widened its interpretation of a law banning most immigrants from receiving federal public benefits.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
Doctors dismissed woman's common symptoms for months... until they discovered she had a deadly colon cancer
A Pennsylvania woman was diagnosed with deadly cancer after being dismissed by doctors. Rylie Toomey, 27, was in the midst of planning her wedding and training for a half marathon when she was struck with unbearable abdominal pain in October 2024. She rushed to the hospital, where doctors performed a CT scan and insisted she was just constipated before sending her home. Doctors told her the same thing when she returned every few months for testing, until she ended up in the emergency department screaming in pain this past April. She was also suffering from a fever. She said: 'In my head I was like, I think I'm going to die - that's how much pain I was in. 'I felt like I was being stabbed, and my belly was super bloated, too. It felt like I was just going to explode.' Toomey had suffered a perforated bowel, meaning there was a hole in her intestinal wall. During that hospital visit, another CT scan detected stage four colon cancer that had spread to her liver and lungs - and she became one of the thousands of young Americans who have been diagnosed with colorectal cancer despite living healthy lives. Toomey told 'When you hear, "You have cancer," you're just like, that can't be right. That can't be me because leading up to this, I was so healthy. 'To hear that I had colon cancer just didn't make sense, just because you feel like colon cancer is linked to unhealthy people or people who eat unhealthy or the elderly. 'I just was not expecting that at all.' The American Cancer Society estimates over 154,000 Americans will be stuck by colorectal cancer this year, including about 20,000 under 50. While this is roughly in line with two decades ago, the disease is rising sharply in younger groups. From 1999 to 2018, the rate of colorectal cancer in the under-50 population rose from 8.6 cases per 100,000 people to 13 cases per 100,000 people. Colorectal cancer diagnoses in 20- to 34-year-olds is set to increase by 90 percent between 2010 and 2030, and rates for teenagers have surged 500 percent since the early 2000s. Lifestyle factors like diet, lack of exercise and a sedentary lifestyle have all been blamed, though these causes fail to explain why physically fit people like Toomey have increasingly been diagnosed with colorectal cancer. The latest evidence, published in April, also suggests childhood exposure to a toxin released by E. coli bacteria could increase the risk of colorectal cancer by triggering inflammation and altering the balance of the gut microbiome. Marijuana was also linked to colorectal cancer in a recent study, as it is thought to block tumor-suppressing cells. Toomey told that she regularly plays lacrosse, runs and cycles and sticks to a healthy diet. She also has no family history of colon cancer. About one in five colorectal cancer patients are diagnosed like Toomey, after a bowel-related emergency often caused by the tumor growing, recent research shows. Toomey is now receiving chemotherapy every two weeks and regular immunotherapy infusions, with eight treatments left. Treatment forced her to push back her wedding, which was supposed to take place last month, and schedule it for June 2026. She said: 'It's definitely something that keeps me going right now. It's kind of hard to stay positive in situations like this, but this is something that's bringing me joy and keeping me going.' Friends have set up a GoFundMe page for medical expenses. Toomey is also urging other young people with symptoms to get checked out immediately and push for answers, even if doctors are dismissive. She said: 'I just don't want anybody to ever go through something like this. I think this happened for a reason so I can help others.'
Daily Mail
2 hours ago
- Daily Mail
Common virus that affects 124million Americans may contribute to debilitating multiple sclerosis
About one in two adults is infected with a virus that can cause cold sores, fever and blisters in the mouth. But now, researchers at the University of Illinois Chicago (UIC) suggest that oral herpes, caused by herpes simplex virus-1 (HSV-1), could also raise the risk of suffering from the life-altering condition multiple sclerosis. In a new study, scientists gene-edited mice not to produce a protein called optineurin, which plays a role in defending the body against herpes infections, and then infected the mice with the virus. The infection led to the rapid degradation of the myelin sheath, a protective coating on nerve fibers. This caused mice to suffer MS-like symptoms, such as muscle weakness, loss of movement and the ability to coordinate muscles. This mirrors the process observed in individuals with multiple sclerosis, where the myelin sheath also degrades because the immune system misfires and starts to attack the area. The scientists say their findings could indicate a link between HSV-1, which is different from the HSV-2 virus that causes genital herpes, and MS. Dr Deepak Shukla, a professor of molecular virology at UIC and the study's lead, said: 'Our findings enhance our understanding of how viruses develop and offer potential avenues for mitigating viral-induced [nerve cell] damage. 'If you are infected, then your immune system is constantly locked in battle with the virus. And if for any reason you become immunocompromised, the virus can escape and damage your brain.' Oral herpes is an extremely common condition that infects about 47 percent of adults, according to the CDC, or 124million people. The virus is spread via sexual contact, such as kissing and oral sex, and is incurable, normally lying dormant and triggering occasional flare-ups of sores on and around the mouth and lips. In cells, it is controlled by the protein optineurin, which stops an infection from spreading and protects against any potential myelin sheath damage. Scientists have previously established that one of the biggest risk factors for MS is an infection with the Epstein-Barr virus (EBV), a virus that has infected 95 percent of adults and which is estimated to raise the risk of MS by 30 percent. And other herpes viruses, like the ones that cause chickenpox, shingles, and human herpes virus 6, have also been linked to the onset and worsening of MS, which affects 1 million Americans. And MS is a debilitating, incurable autoimmune condition that affects the brain and spinal cord and leaves people with mobility issues, memory loss and fatigue. In earlier studies, Dr Shukla's team found that HSV-1 triggered a strong immune response in the brains of mice, causing memory problems, poor coordination, and anxiety. They also discovered that the protein optineurin helps fight the virus by slowing its growth and spread. In the latest study, researchers infected mice that could not produce the protein with the oral herpes virus in their eyes. As seen in earlier cell tests, mice without optineurin had higher infection rates after four days. The researchers also found that a protein called MLKL, or Mixed Lineage Kinase Domain-Like protein, which is made by the body during cell death, boosted HSV-1 infections in the absence of optineurin. Researchers said the protein facilitated the transportation of the virus into a cell's nucleus, speeding an infection, and optineurin controlled HSV-1 infection by triggering the deterioration of MLKL. Imaging studies revealed extensive clumping, or aggregation, of MLKL in the brains of optineurin-lacking mice, but not in control mice, in response to HSV-1 infection. Also, these clumps appeared to trigger the death of myelin-producing oligodendrocytes, or cells that create armor, or the myelin sheath, around neurons. Without the sheath, the nervous system was left vulnerable to damage. The resulting damage disrupts the communication between the brain and the rest of the body, leading to the various symptoms associated with MS, such as weakness in the legs, fatigue, coordination problems, cognitive changes, and pain. Identifying this protein offers a new target for multiple sclerosis therapies. Already, Shukla's lab has demonstrated that necrosulfonamide, which inhibits optineurin, can preserve nerve function in animal models. Studies like these provide hope for the future of MS, and bring about the potential to enable earlier intervention or a possible cure.
The Independent
2 hours ago
- The Independent
Urgent care clinics are pushing pain pills that do little to treat conditions, new study finds
Urgent care clinics are reportedly pushing pills that do little to treat patients' medical conditions. Researchers said Tuesday that a substantial number of antibiotic, glucocorticoid, and opioid prescriptions were filled despite being deemed inappropriate given the patients' diagnoses — potentially resulting in harm. Antibiotics are commonly used to treat infections, glucocorticoids are steroids that can treat arthritis and asthma, and opioids are prescribed to treat pain. America's opioid epidemic, which has led to thousands of deaths, has been tied to an increase in painkiller prescriptions. "Previous studies had shown that patients continue to receive antibiotics for diagnoses where they may not be indicated, such as for a viral respiratory infection, especially in urgent care settings,' Dr. Shirley Cohen-Mekelburg, an assistant professor at the University of Michigan Medical School, said in a statement. 'Our findings reveal that this trend of inappropriate prescribing includes other classes of drugs — including glucocorticoids — and a variety of conditions.' The reason for these findings, they suggest, is tied to the knowledge of clinic doctors, demand from patients, and a lack of an information system to support the clinicians' decisions. "I think that opioids are generally overprescribed when the medical staff under appreciates the risks," Dr. Andrew Kolodny, medical director of the Opioid Policy Research Collaborative at Brandeis University, told MedPage Today. "If the clinicians understood that their prescriptions were more likely to harm patients than help them, I think they'd prescribe more cautiously." Kolodny, who was not involved in the study, said that while opioid prescribing in general has been improving, data shows that 'we've got a long way to go when it comes to urgent care settings.' There are currently more than 14,000 urgent care centers located across the U.S.. They exist to bridge the gap between primary and emergency care, the Urgent Care Association notes. Many of these clinics have their own pharmacies and accept most insurance plans, according to the The American Journal of Managed Care. Using data from more than 22 million urgent care visits between 2018 to 2022, the researchers found that the visits resulted in nearly 2.8 million antibiotic prescriptions, more than 2 million prescriptions of glucocorticoids, and 299,210 opioid prescriptions. Of those, the fractions of the cases were categorized as 'never appropriate' or 'generally inappropriate,' with drugs handed out for health conditions the drugs were not meant to treat. Some 46 percent of patients with urinary symptoms received inappropriate prescriptions of antibiotics and 41 percent of patients with bronchitis received inappropriate prescriptions of glucocorticoids. The cases were also related to middle-ear infections, sinus infections, non-back musculoskeletal pain, abdominal pain, digestive symptoms, and sprains and strains. It was not immediately clear what the effects of these prescriptions were, or if they had resulted in any harm. The researchers suggest that drug stewardship programs to optimize use of the drugs, using electronic health records, and further medication education could have an effect. 'Reducing inappropriate prescribing of antibiotics, glucocorticoids and opioids will require a multifaceted approach,' Cohen-Mekelburg said. 'Providers at urgent centers would benefit from greater support and feedback in making these decisions.'
